70 related articles for article (PubMed ID: 18573919)
1. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Mäkinen A; Härkönen T; Ilonen J; Knip M;
Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
[TBL] [Abstract][Full Text] [Related]
2. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
3. Predictors of Progression From the Appearance of Islet Autoantibodies to Early Childhood Diabetes: The Environmental Determinants of Diabetes in the Young (TEDDY).
Steck AK; Vehik K; Bonifacio E; Lernmark A; Ziegler AG; Hagopian WA; She J; Simell O; Akolkar B; Krischer J; Schatz D; Rewers MJ;
Diabetes Care; 2015 May; 38(5):808-13. PubMed ID: 25665818
[TBL] [Abstract][Full Text] [Related]
4. A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in Diabetes Prevention Trial-Type 1 (DPT-1) participants.
Sosenko JM; Skyler JS; Palmer JP; Krischer JP; Cuthbertson D; Yu L; Schatz DA; Orban T; Eisenbarth G;
Diabetes Care; 2011 Nov; 34(11):2435-7. PubMed ID: 21911777
[TBL] [Abstract][Full Text] [Related]
5. IA-2 antibody isotypes and epitope specificity during the prediabetic process in children with HLA-conferred susceptibility to type I diabetes.
Hoppu S; Härkönen T; Ronkainen MS; Simell S; Hekkala A; Toivonen A; Ilonen J; Simell O; Knip M
Clin Exp Immunol; 2006 Apr; 144(1):59-66. PubMed ID: 16542366
[TBL] [Abstract][Full Text] [Related]
6. Maternal dietary supplement use and development of islet autoimmunity in the offspring: TEDDY study.
Silvis K; Aronsson CA; Liu X; Uusitalo U; Yang J; Tamura R; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler A; Akolkar B; Krischer J; Virtanen SM; Norris JM;
Pediatr Diabetes; 2019 Feb; 20(1):86-92. PubMed ID: 30411443
[TBL] [Abstract][Full Text] [Related]
7. Predicting Islet Cell Autoimmunity and Type 1 Diabetes: An 8-Year TEDDY Study Progress Report.
Krischer JP; Liu X; Vehik K; Akolkar B; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Lernmark Å;
Diabetes Care; 2019 Jun; 42(6):1051-1060. PubMed ID: 30967432
[TBL] [Abstract][Full Text] [Related]
8. Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.
Sharma A; Liu X; Hadley D; Hagopian W; Chen WM; Onengut-Gumuscu S; Törn C; Steck AK; Frohnert BI; Rewers M; Ziegler AG; Lernmark Å; Toppari J; Krischer JP; Akolkar B; Rich SS; She JX;
J Autoimmun; 2018 May; 89():90-100. PubMed ID: 29310926
[TBL] [Abstract][Full Text] [Related]
9. Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes.
Lernmark Å; Akolkar B; Hagopian W; Krischer J; McIndoe R; Rewers M; Toppari J; Vehik K; Ziegler AG;
J Intern Med; 2023 Aug; 294(2):145-158. PubMed ID: 37143363
[TBL] [Abstract][Full Text] [Related]
10. Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young.
Norris JM; Kroehl M; Fingerlin TE; Frederiksen BN; Seifert J; Wong R; Clare-Salzler M; Rewers M
Diabetologia; 2014 Feb; 57(2):295-304. PubMed ID: 24240437
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of children diagnosed with type 1 diabetes before vs after 6 years of age in the TEDDY cohort study.
Krischer JP; Liu X; Lernmark Å; Hagopian WA; Rewers MJ; She JX; Toppari J; Ziegler AG; Akolkar B;
Diabetologia; 2021 Oct; 64(10):2247-2257. PubMed ID: 34291312
[TBL] [Abstract][Full Text] [Related]
12. Role of Type 1 Diabetes-Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study.
Törn C; Hadley D; Lee HS; Hagopian W; Lernmark Å; Simell O; Rewers M; Ziegler A; Schatz D; Akolkar B; Onengut-Gumuscu S; Chen WM; Toppari J; Mykkänen J; Ilonen J; Rich SS; She JX; Steck AK; Krischer J;
Diabetes; 2015 May; 64(5):1818-29. PubMed ID: 25422107
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal Metabolome-Wide Signals Prior to the Appearance of a First Islet Autoantibody in Children Participating in the TEDDY Study.
Li Q; Parikh H; Butterworth MD; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Fiehn O; Fan S; Krischer JP;
Diabetes; 2020 Mar; 69(3):465-476. PubMed ID: 32029481
[TBL] [Abstract][Full Text] [Related]
14. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease.
Elding Larsson H; Vehik K; Gesualdo P; Akolkar B; Hagopian W; Krischer J; Lernmark Å; Rewers M; Simell O; She JX; Ziegler A; Haller MJ;
Pediatr Diabetes; 2014 Mar; 15(2):118-26. PubMed ID: 24034790
[TBL] [Abstract][Full Text] [Related]
15. Plasma Metabolome and Circulating Vitamins Stratified Onset Age of an Initial Islet Autoantibody and Progression to Type 1 Diabetes: The TEDDY Study.
Li Q; Liu X; Yang J; Erlund I; Lernmark Å; Hagopian W; Rewers M; She JX; Toppari J; Ziegler AG; Akolkar B; Krischer JP;
Diabetes; 2021 Jan; 70(1):282-292. PubMed ID: 33106256
[TBL] [Abstract][Full Text] [Related]
16. The KAG motif of HLA-DRB1 (β71, β74, β86) predicts seroconversion and development of type 1 diabetes.
Zhao LP; Papadopoulos GK; Lybrand TP; Moustakas AK; Bondinas GP; Carlsson A; Larsson HE; Ludvigsson J; Marcus C; Persson M; Samuelsson U; Wang R; Pyo CW; Nelson WC; Geraghty DE; Rich SS; Lernmark Å;
EBioMedicine; 2021 Jul; 69():103431. PubMed ID: 34153873
[TBL] [Abstract][Full Text] [Related]
17. Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.
Wyatt RC; Hagopian WA; Roep BO; Patel KA; Resnick B; Dobbs R; Hudson M; ; De Franco E; Ellard S; Flanagan SE; Hattersley AT; Oram RA; Johnson MB
Diabetologia; 2022 Jul; 65(7):1179-1184. PubMed ID: 35501400
[TBL] [Abstract][Full Text] [Related]
18. Early Infant Diet and Islet Autoimmunity in the TEDDY Study.
Uusitalo U; Lee HS; Andrén Aronsson C; Vehik K; Yang J; Hummel S; Silvis K; Lernmark Å; Rewers M; Hagopian W; She JX; Simell O; Toppari J; Ziegler AG; Akolkar B; Krischer J; Virtanen SM; Norris JM;
Diabetes Care; 2018 Mar; 41(3):522-530. PubMed ID: 29343517
[TBL] [Abstract][Full Text] [Related]
19. Distinct cellular immune responses in children en route to type 1 diabetes with different first-appearing autoantibodies.
Starskaia I; Valta M; Pietilä S; Suomi T; Pahkuri S; Kalim UU; Rasool O; Rydgren E; Hyöty H; Knip M; Veijola R; Ilonen J; Toppari J; Lempainen J; Elo LL; Lahesmaa R
Nat Commun; 2024 May; 15(1):3810. PubMed ID: 38714671
[TBL] [Abstract][Full Text] [Related]
20. No Contribution of GAD-65 and IA-2 Autoantibodies around Time of Diagnosis to the Increasing Incidence of Juvenile Type 1 Diabetes: A 9-Year Nationwide Danish Study.
Thorsen SU; Pipper CB; Mortensen HB; Pociot F; Johannesen J; Svensson J
Int J Endocrinol; 2016; 2016():8350158. PubMed ID: 27818684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
